C. Catassi et al., DOSE-DEPENDENT EFFECTS OF PROTRACTED INGESTION OF SMALL AMOUNTS OF GLIADIN IN CELIAC-DISEASE CHILDREN - A CLINICAL AND JEJUNAL MORPHOMETRICSTUDY, Gut, 34(11), 1993, pp. 1515-1519
This study aimed to investigate the effects of chronic ingestion of sm
all amounts of gliadin on children with coeliac disease. A four week c
hallenge was performed on 20 children who had been on a gluten free di
et for mean (SD) 14 (3) months. They were given a daily dose of either
100 mg (group A, n=10, mean age 4 (2) years) or 500 mg of gliadin (gr
oup B, mean age 5 (3) years). The effects of the gliadin were monitore
d by morphometric study of the jejunal mucosa, intestinal permeability
test with cellobiose/mannitol, and serum antigliadin antibody test. A
fter the challenge, group A patients showed a significant increase in
the mean intraepithelial lymphocyte count (before challenge 11 (3), af
terwards 19 (6)) and a decrease in the villous height/crypt depth rati
o (beforehand 1.5 (0.1), afterwards 1.3 (0.2)), while the intestinal p
ermeability test remained normal and the IgA-antigliadin antibody incr
eased in four of 10 children. After the challenge group B showed more
pronounced histological changes, an increase in the mean urinary cello
biose/mannitol % (beforehand 0.028 (0.020), afterwards 0.058 (0.028)),
and IgA-antigliadin antibody positivity in six of eight subjects. The
discriminant analysis function showed that the pretreatment group, gr
oup A after challenge, and group B after challenge were correctly clas
sified in 90% of cases by functions based on the individual intraepith
elial lymphocyte count and the villous height/crypt depth ratio. This
study shows that chronic ingestion of small amounts of gluten causes d
ose-dependent damage to the small intestinal mucosa in children with c
oeliac disease. The predictive value of laboratory tests, such as the
antigliadin antibody test and the intestinal permeability test seems t
o be lower in treated patients than in those with active coeliac disea
se.